Cargando…
Clinical performance evaluation of BD SARS-CoV-2 reagents for BD MAX(TM) System in asymptomatic individuals
Transmission by asymptomatic individuals is a persistent hurdle in the effort to control the spread of SARS-CoV-2. Therefore, it is essential to continue developing assays and evaluate their performance for detection of SARS-CoV-2 in individuals without COVID-19 symptoms. In this study, 223 nasophar...
Autores principales: | Yanson, Karen, Laviers, William, Suhaidi, Faten, Greeley, Zachary, Merryman, Courtney, Proctor, Reda, Hall, Dominique, Neely, Lori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671610/ https://www.ncbi.nlm.nih.gov/pubmed/36495738 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115861 |
Ejemplares similares
-
Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System
por: Yanson, Karen, et al.
Publicado: (2021) -
Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system
por: Paradis, Sonia, et al.
Publicado: (2021) -
How to Interpret a Positive Campylobacter PCR Result Using the BD MAX(TM) System in the Absence of Positive Culture?
por: Gueudet, Thomas, et al.
Publicado: (2019) -
Clinical Performance of the BD CTGCTV2 Assay for the BD MAX System for Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections
por: Van Der Pol, Barbara, et al.
Publicado: (2021) -
BdCESA7, BdCESA8, and BdPMT Utility Promoter Constructs for Targeted Expression to Secondary Cell-Wall-Forming Cells of Grasses
por: Petrik, Deborah L., et al.
Publicado: (2016)